SELECT2: A Randomized Controlled Trial to Optimize Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- (Australia and Oceania) Bruce CV Campbell, MBBS PhD
Melbourne Health
Principal Investigator - (Europe) Marc Ribo, MD
Vall d'Hebron University Hospital, Barcelona
Principal Investigator - Amrou Sarraj, MD
Case Western Reserve University - University Hospitals Cleveland Medical Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
31 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Liverpool Hospital - South Western Sydney Clinical School
Liverpool, New South Wales, Australia
- the Royal Adelaide Hospital (rah)
Adelaide, South Australia, Australia
- Royal Melbourne Hospital
Melbourne, Victoria, Australia
- University of Alberta
Edmonton, Alberta, Canada
- University Health Network - Toronto Western Hospital
Toronto, Ontario, Canada
- Christchurch Hospital
Christchurch, Canterbury, New Zealand
- Hospital Universitario Germans Trias I Pujol
Badalona, Spain
- Hospital Clínic I Provincial de Barcelona
Barcelona, Spain
- Hospital Universitari Vall D'Hebron
Barcelona, Spain
- Hospital Universitari de Bellvitge
Barcelona, Spain
- Hospital Clínico Universitario de Valladolid
Valladolid, Spain
- Universität Basel
Basel, Switzerland
- Kaiser Permanente
Los Angeles, California, United States
- Baptist Health
Jacksonville, Florida, United States
- Rush University Medical Center
Chicago, Illinois, United States
- Ascension St. Vincent Hospital
Indianapolis, Indiana, United States
- University of Iowa Hospitals and Clinics
Iowa City, Iowa, United States
- University of Kansas Medical Center
Kansas City, Kansas, United States
- Spectrum Health Hospital
Grand Rapids, Michigan, United States
- Westchester Medical Center
Valhalla, New York, United States
- Cleveland Clinic Foundation
Cleveland, Ohio, United States
- University Hospitals Cleveland Medical Center
Cleveland, Ohio, United States
- Riverside Methodist Hospital - Ohiohealth
Columbus, Ohio, United States
- Abington Jefferson Health
Abington, Pennsylvania, United States
- the Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States
- Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, United States
- Semmes Murphey Clinic - University of Tennessee Health Science Center
Memphis, Tennessee, United States
- Dell Seton Medical Center at the University of Texas at Austin
Austin, Texas, United States
- Valley Baptist Medical Center
Harlingen, Texas, United States
- the University of Texas Health Science Center at Houston
Houston, Texas, United States
- Ascension Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 11 Oct 2019
- Primary completion
- 20 Nov 2022
- Completion
- 16 Nov 2023
- Last update posted
- 21 Nov 2024
- Registered enrollment
- 352
- Registry id
- NCT03876457
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.